Ana Ruiz‐Casado

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Navesh Sharma, Volker Heinemann et al. · The Lancet Oncology · 2017 · 398 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Cisplatin Plus Gemcitabine Versus a Cisplatin-Based Triplet Versus Nonplatinum Sequential Doublets in Advanced Non–Small-Cell Lung Cancer: A Spanish Lung Cancer Group Phase III Randomized Trial

V. Alberola, Carlos Camps, Mariano Provencio et al. · Journal of Clinical Oncology · 2003 · 193 citations

Medicine, Oncology, Pharmacology +14

Addition of Bevacizumab to XELOX Induction Therapy Plus Concomitant Capecitabine-Based Chemoradiotherapy in Magnetic Resonance Imaging–Defined Poor-Prognosis Locally Advanced Rectal Cancer: The AVACROSS Study

Miguel Nogué, Antonieta Salud, Pilar Vicente et al. · The Oncologist · 2011 · 155 citations · Full text

Medicine, Oncology, Surgery +17

Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma

Caroline Laverdière, E. Anders Kolb, Jeffrey G. Supko et al. · Cancer · 2003 · 98 citations

Medicine, Oncology, Pharmacokinetics +15

ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated <i>BRAF</i>^V600E-Mutant Metastatic Colorectal Cancer

Eric Van Cutsem, Rona Yaeger, Takayuki Yoshino et al. · Journal of Clinical Oncology · 2023 · 94 citations · Full text

Medicine, Oncology, Pharmacology +12